Products
Products

Portfolio

Committed to better health for individuals, Takeda Pharmaceuticals North America, Inc. (TPNA) develops and markets innovative pharmaceutical treatments.

In addition to the success of our on-the-market products, Takeda invests in an active R&D pipeline in an effort to bring new treatments to patients in need.

Click here for more R&D pipeline information.

The following prescription drugs are listed for physicians and healthcare professionals.

Click on the product links for more detailed information.

Brand Name
Click name for product and important safety information.		 Generic Name Prescribing Information
ACTOS pioglitazone HCl Prescribing Information including boxed warning and medication guide
ACTOplus met pioglitazone HCl and metformin HCl Prescribing Information including boxed warning and medication guide
ACTOplus met XR pioglitazone HCl and metformin HCl
(extended release)		 Prescribing Information including boxed warning and medication guide
Duetact pioglitazone HCl and glimepiride Prescribing Information including boxed warning and medication guide
AMITIZA lubiprostone Prescribing Information
DEXILANT

DEXILANT(dexlansoprazole) is formerly known as KAPIDEX (dexlansoprazole)

 dexlansoprazole Prescribing Information
EDARBI azilsartan medoxomil Prescribing Information including boxed warning
EDARBYCLOR azilsartan medoxomil and chlorthalidone Prescribing Information including boxed warning
PREVACID lansoprazole Prescribing Information
PREVPAC lansoprazole/amoxicillin/clarithromycin Prescribing Information
ROZEREM ramelteon Prescribing Information including medication guide
ULORIC febuxostat Prescribing Information

ACTOS, ACTOplus met, ACTOplus met XR, and duetact are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

DEXILANT and DEXILANT (with design) are trademarks of Takeda Pharmaceuticals North America, Inc., registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

EDARBI is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

EDARBYCLOR is a trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals America, Inc.

PREVACID is a trademark registered in the U.S. Patent and Trademark Office and SoluTab is a trademark of Takeda Pharmaceuticals North America, Inc. and used under license by Takeda Pharmaceuticals America, Inc.

PREVPAC and PREVACID are trademarks of Takeda Pharmaceuticals North America, Inc. registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

Rozerem is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

ULORIC is a trademark of Teijin Pharma Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

Please click here to view Takeda’s authorized wholesalers and distributors.





Page Top